42nd Annual Miami Breast Cancer Conference®

Women in Oncology Brunch (Non-CE)

Breakfast

Ask The Expert

CE-Certified Satellite Symposium: Medical Crossfire® Translating Evidence Into Clinical Practice in Early-Stage HR+, HER2– Breast Cancer

Welcome

Tumor Board Session I

Faculty Lunch With Fellows

Lunch & Non-CE Product Theater: Explore the current data that could help you recognize/assess candidates for a CDK4 & 6 inhibitor

Molecular Tumor Board Session II

Coffee Break

Tumor Board Session III

ADJOURNMENT

Welcome Reception and Poster Session/Early Career Poster Walk

Dinner

CE-Certified Satellite Symposium:  Cases and Conversations: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Welcome and Opening Remarks

Active Monitoring vs Surgery for Ductal Carcinoma In Situ

Contrast Mammography: A Better Mammogram

New Evidence for Combining RT and Breast Reconstruction

Surgical Strategies for Prevention and Management of Lymphedema

Panel Discussion

Summary and ARS

CE-Certified Satellite Symposium Coffee Talk™: Navigating the Impact of HER2, HER3 and TROP2 From Early-Stage to Advanced Breast Cancer Care

Giants of Cancer Care® Lecture: Tackling Racial Disparities in Breast Cancer

Tailored Strategies for HER2+ Breast Cancer: Neoadjuvant and Adjuvant Approaches

Do All Premenopausal Women With Node-Positive Breast Cancer Need Chemo?

Neoadjuvant Endocrine Therapy in Pre- and Postmenopausal Women

Lunch & Non-CE Product Theater: Evolving Strategies for HR+/HER2- (IHC 0, IHC 1+, IHC 2+/ISH-) mBC

Lunch & Non-CE Product Theater:Treatment Considerations for Specific Populations With HR+/HER2- mBC

Welcome | Breakout Sessions

Growing Evidence for Hypofractionation | Radiation Oncology Session

Preoperative Breast MRI: Best Practices and Indications | Surgical Oncology Session

Strategic Therapeutic Sequencing for Germline and Somatic Mutations in Breast Cancer | Medical Oncology Session

Evolving Approaches to Select Candidates for RT Omission After Breast Conservation | Radiation Oncology Session

Navigating Endocrine Therapy: Managing Treatment-Related Toxicities | Medical Oncology Session

Neoadjuvant Endocrine Therapy: Surgical Perspectives | Surgical Oncology Session

Delayed Sentinel Node Biopsy: Implications for Breast Cancer Surgery | Surgical Oncology Session

Sequencing Targeted Therapies in HR+ Metastatic Breast Cancer: Who Should Receive CDK4/6 After CDK4/6? | Medical Oncology Session

The Influence of Germline Genetic Testing on RT | Radiation Oncology Session

Key End Points for Neoadjuvant Trials in Breast Cancer | Surgical Oncology Session

Medical Crossfire®: Which Patients with DCIS Should Receive Biologic Signature Risk Recurrence Testing? | Radiation Oncology Session

Sequencing and Optimal Timing of ADCs in HER2-Negative Breast Cancer | Medical Oncology Session

ERAS Protocols and Multimodal Analgesia in Breast Surgery | Surgical Oncology Session

Managing Brain Metastases in HER2+ Breast Cancer | Medical Oncology Session

An Enigmatic Requiem for William Stewart Halsted | Surgical Oncology Session

Key Updates on the RT Management of DCIS | Radiation Oncology Session

Medical Crossfire®: Chemotherapy and Gene Expression Testing vs Gene Expression Testing and Best Endocrine Therapy for a 45-Year-Old With Grade 2 Invasive Ductal Carcinoma | Medical Oncology Session

Get-Acquainted Reception

Meet the Faculty – Case Discussions

Poster Session and Early Career Poster Walk

CE-Certified Satellite Symposium: Innovations in HR+/HER2– Metastatic Breast Cancer: Advancing Care Through PROTAC ER Degradation

Faculty Dinner (Invite-Only Event)

CE-Certified Satellite Symposium: Medical Crossfire®: Exploring Emerging Next-Generation Endocrine Therapies in ER+/HER2– Breast Cancer—Evaluating the Potential of Future Treatments

Key Highlights From the Lancet Breast Cancer Commission

Defining Best Practices: The Role of Guidelines in Setting Treatment Standards in Breast Cancer Care

Adjuvant CDK4/6 Inhibitors: Efficacy and Best Practices

Addressing Disparities in Breast Cancer: TNBC in African American Women

CURE® Educated Patient® Breast Cancer Summit

Genetic Testing in Breast Cancer: Identifying Candidates

Emerging Therapies: Updates on Oral SERDs for Metastatic HR+ Breast Cancer

Medical Crossfire®: Do You Usually Order MRI for a Young Patient (BRCA1/2 Pathogenic Carrier?)

The Patti Hennessy Keynote Address

Scientific Keynote Address: Identifying and Quantifying the Hidden Costs of Breast Cancer: The First Step in Alleviating Unrecognized Suffering

Audience Question & Answer

Lunch & Non-CE Product Theater: Addressing the Needs of Patients Across the HR+ HER2- Landscape

Lunch & Non-CE Product Theater: New Treatment Option in HER2-Expressing mBC

Extended Endocrine Therapy in Early-Stage Breast Cancer: Who, What, & How Long? | Medical Oncology Session

Precision Oncology: Biomarkers in Breast Cancer | Oncology Nursing Session

Radiation-Induced Cardiotoxicity in Patients with Breast Cancer | Radiation Oncology Session

Reconstruction Considerations Following Radiation | Surgical Oncology Session

Best Practices for Breast Cancer Care in Older Adults | Oncology Nursing Session

Can I Get Pregnant After Breast Cancer? | Medical Oncology Session

Tailoring Locoregional Therapy After Neoadjuvant Chemotherapy | Radiation Oncology Session

Up-Front Axillary Surgical Management: Deescalation Strategies for Ultrasound-Detected Nodal Disease? | Surgical Oncology Session

Evidence-based Therapies and Not-So-Magic Cures for Sexual Health Concerns After Breast Cancer | Oncology Nursing Session

IORT: Is It Dead? | Radiation Oncology Session

Targeted Axillary Staging: Precision in Breast Cancer Management | Surgical Oncology Session

Unique Challenges in Managing Metastatic Breast Cancer in Younger Patients | Medical Oncology Session

Difficult Conversations Across the Breast Cancer Care Continuum | Oncology Nursing Session

How to Engage Patients in Decision-Making When Sorting Through Many Appropriate Options | Radiation Oncology Session

Medical Crossfire®: Axillary Lymph Node Surgery After Sentinel Lymph Node Biopsy? | Surgical Oncology Session

Optimizing Treatment for Node-Negative ER+ Breast Cancer | Medical Oncology Session

Cases and Conversations: Approaches to Grief, Palliative Care, and the End of Life | Oncology Nursing Session

CE-Certified Satellite Symposium: Cases and Conversations: Tailored Treatment Approaches for Older Patients With Advanced HR+/HER2– Breast Cancer | Medical Oncology Session

CE-Certified Satellite Symposium: Shaping Surgical Pathways: Revolutionizing Breast Cancer Care With Genetic Testing and Targeted Treatment | Surgical Oncology Session

Coffee Break | Radiation Oncology Session

Coffee Break | Oncology Nursing Session

Emerging Data and Key Updates in Breast Cancer Care for Oncology Nursing: Where We Stand in 2025 | Oncology Nursing Session

Meet the Faculty—Case Discussions

Adverse Event Management in Breast Cancer: Addressing Toxicities From Surgery, Radiation, Endocrine Therapy, and Beyond | Oncology Nursing Session

Cardio-Oncology in Breast Cancer Care: Nursing Roles in Monitoring and Managing Cardiotoxicity and Mitigating Cardiovascular Risks | Oncology Nursing Session

Panel Discussion: Navigating Breast Cancer Care in Young Patients | Oncology Nursing Session

Closing Reception

Breakfast & CE-Certified Satellite Symposium: Updates and Innovations in Non-Opioid Pain Management Strategies for Breast Cancer Patients Post-Surgical Intervention

Estrogens and Androgens in Patients With ER+ Breast Cancer

Managing Breast Cancer in Pregnancy: Challenges and Considerations

Optimizing Treatment for Early TNBC: Best Practices for Neoadjuvant vs Adjuvant Therapy